We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What to Expect From Medical Properties' (MPW) Q2 Earnings?
Read MoreHide Full Article
Medical Properties Trust, Inc. (MPW - Free Report) — also known as MPT — is scheduled to report second-quarter 2019 results on Aug 1, before the market opens. The company’s results will likely reflect year-over-year decline in its funds from operations (FFO) and revenues.
In the last reported quarter, this self-advised real estate investment trust (REIT), which acquires and develops net-leased healthcare facilities, posted normalized funds from operations (NFFO) per share of 31 cents, missingthe Zacks Consensus Estimate by a whisker.
Over the trailing four quarters, the company met the Zacks Consensus Estimate on one occasion, missed in another and met in the other two. It reported an average negative surprise of 0.05% during this period. The graph below depicts this surprise history:
Medical Properties Trust, Inc. Price and EPS Surprise
Let’s see how things are shaping up prior to this announcement.
Factors to Consider
The acute healthcare real estate opportunity is rapidly expanding with significant domestic and international potential acquisition targets. In fact, the U.S. hospital real estate is estimated to be valued at $0.5 trillion. Moreover, operators and owners have resorted to consolidation of hospital systems in search for cost efficiencies and economies of scale.
Amid this, MPT has consistently scaled its global hospital real estate portfolio with approximately $6 billion of investments since 2016. In the second quarter too, a favorable hospital acquisition environment enabled the company to make progress with respect to its $2.5-billion investment pipeline for 2019, with the acquisition of interest in Infracore SA, and the purchase of 11 Australian hospitals operated by Healthscope Ltd.
Specifically, in May, the company became the largest shareholder in Infracore’s real estate by acquiring 46% stake in the Swiss healthcare real estate company, for cash equity investment of $236.5 million. The transaction enabled the company to foray into the Swiss healthcare market.
Additionally, in June, the company completed the previously-announced A$1.2-billion acquisition of the real estate interests of 11 Australian hospitals operated by Healthscope Ltd.Long-term inflation-protected rents from these properties will be strongly accretive to the company’s FFO per share for the quarter.
Notably, healthcare REITs are benefiting from higher healthcare spending and the demographic boom which is being fueled by the aging baby boomers. In fact, going by a presentation, nearly 10,000 baby boomers will turn 65 every day through 2030. Hence, the company’s focus to scale its portfolio while simultaneously achieve asset and geographic diversification is a strategic fit.
Nevertheless, the company’s results are tied to its tenant operators’ performances, which, in turn,are exposed to greater volatility due to reimbursement and regulatory risks. Given MPT’s high tenant concentration, its earnings are likely to be more volatile. In fact, Steward Healthcare, Prime Healthcare and Median account for significant part of MPT’s top line.
In addition, the Zacks Consensus Estimate for second-quarter revenues is pegged at $188 million. This represents a year-over-year decline of 6.9% from the year-earlier quarter’s reported tally.
Lastly, prior to the second-quarter earnings release, the company has been witnessing downward estimate revisions. As such, the Zacks Consensus Estimate of FFO per share for the quarter under review has been revised marginally downward to 31 cents over the past month, reflecting analysts’ bearish sentiments. Also, it represents a year-over-year decline of 13.9%.
Earnings Whispers
Our proven model does not conclusively show that MPT is likely to beat estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or at least 3 (Hold) for this to happen. That is not the case here, as you will see below.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earning ESP: MPT’s Earnings ESP is -1.41%.
Zacks Rank: The company currently carries a Zacks Rank of 3, which increases the predictive power of ESP. However, we also need a positive ESP to be confident of an earnings beat.
Stocks That Warrant a Look
Several other players in REIT space are lined up to report their financial results. Below are three stocks, poised to beat on earnings, per the proven Zacks model. You can see the complete list of today’s Zacks #1 Rank stocks here.
CyrusOne Inc. , scheduled to release earnings on Jul 31, has an Earnings ESP of +1.37% and carries a Zacks Rank #3, at present.
Equity Commonwealth (EQC - Free Report) , slated to report quarterly figures on Jul 31, has an Earnings ESP of +3.23% and sports a Zacks Rank of 1, currently.
Healthcare Realty Trust Incorporated (HR - Free Report) , set to release June-end quarter results on Jul 30, has an Earnings ESP of +0.72% and currently holds a Zacks Rank #3.
Note: Anything related to earnings presented in this write-up represent funds from operations (FFO) — a widely used metric to gauge the performance of REITs.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Image: Bigstock
What to Expect From Medical Properties' (MPW) Q2 Earnings?
Medical Properties Trust, Inc. (MPW - Free Report) — also known as MPT — is scheduled to report second-quarter 2019 results on Aug 1, before the market opens. The company’s results will likely reflect year-over-year decline in its funds from operations (FFO) and revenues.
In the last reported quarter, this self-advised real estate investment trust (REIT), which acquires and develops net-leased healthcare facilities, posted normalized funds from operations (NFFO) per share of 31 cents, missingthe Zacks Consensus Estimate by a whisker.
Over the trailing four quarters, the company met the Zacks Consensus Estimate on one occasion, missed in another and met in the other two. It reported an average negative surprise of 0.05% during this period. The graph below depicts this surprise history:
Medical Properties Trust, Inc. Price and EPS Surprise
Medical Properties Trust, Inc. price-eps-surprise | Medical Properties Trust, Inc. Quote
Let’s see how things are shaping up prior to this announcement.
Factors to Consider
The acute healthcare real estate opportunity is rapidly expanding with significant domestic and international potential acquisition targets. In fact, the U.S. hospital real estate is estimated to be valued at $0.5 trillion. Moreover, operators and owners have resorted to consolidation of hospital systems in search for cost efficiencies and economies of scale.
Amid this, MPT has consistently scaled its global hospital real estate portfolio with approximately $6 billion of investments since 2016. In the second quarter too, a favorable hospital acquisition environment enabled the company to make progress with respect to its $2.5-billion investment pipeline for 2019, with the acquisition of interest in Infracore SA, and the purchase of 11 Australian hospitals operated by Healthscope Ltd.
Specifically, in May, the company became the largest shareholder in Infracore’s real estate by acquiring 46% stake in the Swiss healthcare real estate company, for cash equity investment of $236.5 million. The transaction enabled the company to foray into the Swiss healthcare market.
Additionally, in June, the company completed the previously-announced A$1.2-billion acquisition of the real estate interests of 11 Australian hospitals operated by Healthscope Ltd.Long-term inflation-protected rents from these properties will be strongly accretive to the company’s FFO per share for the quarter.
Notably, healthcare REITs are benefiting from higher healthcare spending and the demographic boom which is being fueled by the aging baby boomers. In fact, going by a presentation, nearly 10,000 baby boomers will turn 65 every day through 2030. Hence, the company’s focus to scale its portfolio while simultaneously achieve asset and geographic diversification is a strategic fit.
Nevertheless, the company’s results are tied to its tenant operators’ performances, which, in turn,are exposed to greater volatility due to reimbursement and regulatory risks. Given MPT’s high tenant concentration, its earnings are likely to be more volatile. In fact, Steward Healthcare, Prime Healthcare and Median account for significant part of MPT’s top line.
In addition, the Zacks Consensus Estimate for second-quarter revenues is pegged at $188 million. This represents a year-over-year decline of 6.9% from the year-earlier quarter’s reported tally.
Lastly, prior to the second-quarter earnings release, the company has been witnessing downward estimate revisions. As such, the Zacks Consensus Estimate of FFO per share for the quarter under review has been revised marginally downward to 31 cents over the past month, reflecting analysts’ bearish sentiments. Also, it represents a year-over-year decline of 13.9%.
Earnings Whispers
Our proven model does not conclusively show that MPT is likely to beat estimates this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or at least 3 (Hold) for this to happen. That is not the case here, as you will see below.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earning ESP: MPT’s Earnings ESP is -1.41%.
Zacks Rank: The company currently carries a Zacks Rank of 3, which increases the predictive power of ESP. However, we also need a positive ESP to be confident of an earnings beat.
Stocks That Warrant a Look
Several other players in REIT space are lined up to report their financial results. Below are three stocks, poised to beat on earnings, per the proven Zacks model. You can see the complete list of today’s Zacks #1 Rank stocks here.
CyrusOne Inc. , scheduled to release earnings on Jul 31, has an Earnings ESP of +1.37% and carries a Zacks Rank #3, at present.
Equity Commonwealth (EQC - Free Report) , slated to report quarterly figures on Jul 31, has an Earnings ESP of +3.23% and sports a Zacks Rank of 1, currently.
Healthcare Realty Trust Incorporated (HR - Free Report) , set to release June-end quarter results on Jul 30, has an Earnings ESP of +0.72% and currently holds a Zacks Rank #3.
Note: Anything related to earnings presented in this write-up represent funds from operations (FFO) — a widely used metric to gauge the performance of REITs.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>